1 Organic cation transporters (OCTs) are involved in the elimination of monoamines and cationic xenobiotics. To examine whether some cell lines express several dierent OCTs, we investigated seven human cell lines for the mRNA expression pattern of the human (h) transporters hOCT1, hOCT2 and hOCT3. hOCT1 mRNA was found in all cell lines, six additionally expressed hOCT3 and only two cell lines contained all three hOCTs. 2 Among the three OCTs only for the OCT3 (also designated as`uptake 2 ' or`extraneuronal monoamine transporter')`selective' inhibitors are described in the literature. The anities of the OCT3 inhibitors for the other two OCTs are largely unknown. Therefore, we compared the potencies of eight compounds as inhibitors of hOCT-mediated uptake of the organic cation [
Introduction
Catecholamines are removed from the circulation by uptake into non-neuronal tissues through the action of the Na + -and Cl
7
-independent, corticosterone-sensitive extraneuronal monoamine transport system`uptake 2 ' whereas synaptically released noradrenaline is mainly transported back into noradrenergic neurones via the Na + -and Cl
-dependent, desipramine-sensitive neuronal noradrenaline transport system`uptake 1 ' (Iversen, 1965; 1973; BoÈ nisch, 1980; Graefe & BoÈ nisch, 1988; Eisenhofer, 2001 ). Molecular cloning of both transporter cDNAs has shown that they belong to two dierent transporter families. While the neuronal noradrenaline transporter is a member of the Na + -and Cl
-dependent monoamine neurotransmitter transporters, the`uptake 2 ' transporter is represented by OCT3 and thus belongs to the family of organic cation transporters (OCTs) which are involved in the absorption, distribution and elimination of endogenous compounds (e.g. amines) as well as of drugs, toxins and other xenobiotics that are positively charged at physiological pH (Eisenhofer, 2001; Burckhardt & Wol, 2000) .
The ®rst cloned OCT has been the rat OCT1 (rOCT1) (GruÈ ndemann et al., 1994) . Meanwhile also the mouse (Schweifer & Barlow, 1996) , rabbit (Terashita et al., 1998) and human OCT1 transporters have been cloned. The human OCT1 (hOCT1) (Zhang et al., 1997; Gorboulev et al., 1997) shows about 80% amino acid (aa) identity to the rOCT1. From the human glioma cell line SK-MG-1 which also expresses an`uptake 2 ' transport system (Streich et al., 1996) we recently isolated four hOCT1 isoforms, the full-length hOCT1 and splice variants (Hayer et al., 1999) .
The rat, human and porcine OCT2 have been cloned from kidney (Okuda et al., 1996; Gorboulev et al., 1997; GruÈ ndemann et al., 1997) , and the human and porcine transporters show about 90% amino acid identity to the rat OCT2.
The rat OCT3 which has been isolated from placenta (Kekuda et al., 1998) represents the`uptake 2 ' transport system (Wu et al., 1998a) . The human OCT3 cDNA has been ampli®ed from the human kidney carcinoma cell line Caki-1 (GruÈ ndemann et al., 1998), which previously had been shown to express the`uptake 2 ' transport system (SchoÈ mig & SchoÈ nfeld, 1990) . All three hOCT genes have been shown to be clustered on the long arm of chromosome 6 (Verhaagh et al., 1999) . The close physical linkage of the three OCT genes and their structural similarities (GruÈ ndemann & SchoÈ mig, 2000; Wieland et al., 2000) indicate that they may have evolved from a common anchestor gene through duplication. Interestingly, the human colon adenocarcinoma cell line Caco-2 expresses the mRNAs of all three human OCTs (Bleasby et al., 2000; Martel et al., 2001) . Therefore, one aim of the present study was to explore by examining a series of human cell lines whether expression of more than one OCT mRNA is a frequent phenomenon in tumour cells.
In spite of the similiarities between the three OCTs little is known about similarities in their pharmacological properties. GruÈ ndemann et al. (1999) have shown some dierences between the three OCTs concerning the transport eciencies of various substrates; however, some of the observed dierences might re¯ect species dierences since the pharmacological properties were examined in rat OCT1, rat OCT2 but human OCT3. Recently, Dresser et al. (2000) have demonstrated that some properties of the human OCT1 dier from those of the mouse, rat and rabbit OCT1 homologues. Species dierences also have been observed between the rat and human OCT2 transporters concerning inhibition of 14 C-TEA uptake by some compounds such as procainamide and MPP + (Koepsell et al., 1999) . Finally, species dierences have also been described for the OCT3: while the rat OCT3 transports MPP + and the prototypic organic cation TEA (Kekuda et al., 1998) , virtually no transport of TEA could be demonstrated for the human homologue (GruÈ ndemann et al., 1998) .
The main aim of the present study was to examine within one species (human) dierences in the pharmacology of the three OCTs. Thus, we cloned the hOCT2-and hOCT3-cDNAs and stably transfected HEK293 cells with hOCT1-, hOCT2-or hOCT3-cDNA. Using these cells we examined inhibition of hOCT-mediated uptake of the organic cation [ 3 H]-MPP + by a series of compounds, which all have previously been shown to inhibit`uptake 2 ' at low micromolar concentrations.
Methods

RT ± PCR
Total RNA from about 10 7 cells each of the human cell lines SK-MG-1 (glioma), Ski-1 (glioma), Caki-1 (kidney carcinoma), HepG-2 (hepatocellular carcinoma), FL (amnion epithelium), Caco-2 (colon adenocarcinoma), and JAR (choriocarcinoma) was isolated (RNeasy Mini Kit, Qiagen, Hilden) and primed with an Oligo(dT) 18 primer to synthesize the ®rst strand cDNA using SuperScriptII Reverse Transcriptase (Gibco, Life Technologies) according to the manufacturer's protocol. Primers for the ampli®cation of full-length hOCT3 were deduced from the 5'-and 3'-nontranslated region of the hOCT3 cDNA (accession number AJ001417) published by GruÈ ndemann et al. (1998) (sense, position: bp 712 ± +12, 5'-GGCGGGCGCACCATGCCCTCCTTC-3'; antisense, position: bp 1711-1685; 5'-GCTCCTGGATAGCTCCTTCTTTC-TGTC-3'). PCR was performed with cDNA from the human glioma cell line SK-MG-1 with the`Fail Safe PCR System' (Biozym) using buer G according to the manufacturer's protocol and the following temperature program: inital denaturation (948C) for 3 min, 948C for 1 min, 688C for 2 min, for 40 cycles, followed by a ®nal 10 min extension at 688C. For the ampli®cation of full length hOCT2, human Marathon kidney cDNA (Clontech, Palo Alto, CA, U.S.A.) was used as template for PCR ampli®cation. Primers were deduced from the 5'-and 3'-nontranslated region of the hOCT2 cDNA (accession number X98333; Gorboulev et al., 1997) (sense, position: 7125-7105, 5'-GTCACTTGCA-GAGGTAAACTC-3'; antisense, position: 1700 ± 1680, 5'-CTAGGTCATGACAGCAGCAAC-3'). PCR was performed using Expand Long Template PCR System (Roche, Germany) and the following temperature program: 948C for 1 min, 628C for 1 min and 688C for 2 min for 40 cycles, followed by a ®nal 10 min extension at 688C. PCR products were separated by electrophoresis on 0.8% agarose gels and the fragments were isolated and subcloned into the pCR2.1 vector (TA Cloning Kit, Invitrogen, Netherlands) using T4 DNA Ligase (Roche, Mannheim, Germany) followed by transformation into E. coli INVaF' competent cells. Plasmid DNA was isolated by means of the Spin Miniprep Kit (Qiagen, Hilden, Germany). The cDNAs were sequenced with an automated sequencer (Li-COR 4200, MWG Biotech, Ebersberg, Germany) and the Thermo Sequenase¯uorescent labelled primer cycle sequencing kit with 7-deaza-dGTP (Amersham, Freiburg, Germany). Sequence alignment was performed by the PC/GENE software (IntelliGenetics).
Ampli®cation of hOCT1, hOCT2 and hOCT3 fragments from the human cell lines was performed using primers (0.2 mM each) deduced from the the published hOCT1, hOCT2 and hOCT3 cDNA sequences: hOCT1 (Zhang et al., 1997 ; accession number U77086): sense bp 1579 ± 1596, 5'-GACGCCGAGAACCTTGGG-3' and antisense bp 1776 ± 1759, 5'-GGGTAGGCAAGTATGAGG-3'; hOCT2 (Gorboulev et al., 1997) : sense bp 691 ± 712, 5'-CGGAGA-TATCGGAGAACAGT-3' and antisense bp 890 ± 870, 5'-GCATTCTTATTCTGGGAGATC-3'; hOCT3 (GruÈ ndemann et al., 1998): sense bp 1408 ± 1431, 5'-GTTTCGCTCTGT-TCAGGTCTGTGT-3' and antisense bp 1881 ± 1861, 5'-TTATGTGTTCCCAGAAACTTC-3'. PCR was performed using 2 U Taq DNA polymerase (Gibco ± BRL), dNTPs (200 mM each), MgCl 2 (2 mM), 16PCR buer, and the following temperature program: initial denaturation (948C) for 2 min, 948C for 30 s, 588C (hOCT1), 548C (hOCT2), 648C (hOCT3) for 30 s, 728C for 30 s for 35 cycles. Betaactin ampli®cation served as internal standard; speci®c primers (sense, bp 840 ± 862, 5'-CACTCTTCCAGCCTTCC-TTCCTG-3' and antisense, bp 1197 ± 1175, 5'-TAGTCCG-CCTAGAAGCATTTGCG-3') were used with the following temperature program: 948C for 1 min, 648C for 30 s, 728C for 1 min, for 25 cycles. The PCR products were separated on 1% agarose gels. The predicted sizes of the PCR products were (in bp): 197 (hOCT1), 199 (hOCT2), 473 (hOCT3) and 357 (b-actin).
Cell lines
For RT ± PCR we used seven established human tumour cell lines: SK-MG-1 (human glioma; a gift from Dr Cairncross, London, Ontario), Ski-1 (human glioma; a gift from Dr Panasci, Montreal, Quebec, Canada), Caki-1 (human kidney carcinoma; ATCC HTB 46), HepG-2 (human hepatoma; ATCC HB-8065), FL (human amnion; ATCC CCL-62), Caco-2 (human colon adenocarcinoma; ATCC HTB-37) and JAR (human placenta choriocarcinoma; ATCC HTB-144). HEK293 (human embryonic kidney; ATCC CRL-1573) cells were used for stable transfection of hOCT1, hOCT2 or hOCT3.
Cell culture
HEK293 cells stably transfected with the cDNAs of hOCT1, hOCT2 or hOCT3 were maintained at 378C in a humi®ed atmosphere (5% CO 2 ) on plastic culture¯asks (Gibco, Life Technologies, Eggenstein, Germany). The medium was DMEM/HAMS F12 (Sigma-Aldrich, Deisenhofen, Germany) supplemented with 10% foetal calf serum (FKS; Biochrom, Berlin Germany), 100 U ml 71 penicillin and 100 mg ml 71 streptomycin. The culture medium was changed every 2 ± 3 days. SK-MG-1, Ski-1 and Caki-1 cells were grown in McCoy's 5A, HepG-2 and FL cells were grown in MEM, JAR cells were grown in RPMI medium (all supplemented with 10% FKS, 100 U ml 71 penicillin and 100 mg ml 71 streptomycin) and Caco-2 cells were grown in DMEM medium supplemented with 20% FKS, 100 U ml 71 penicillin and 100 mg ml 71 streptomycin.
Stable transfection of hOCT1, hOCT2 and hOCT3
Full-length hOCT1 cDNA was subcloned into the mammalian expression vector pcDNA3 (Invitrogen, Netherlands), full-length hOCT2 and hOCT3 were subcloned into the mammalian expression vector pIRESneo (Invitrogen, Netherlands) and HEK293 cells were transfected with these vectors by the modi®ed calcium phosphate precipitation method (Chen & Okayama, 1987) . Selection of stably transfected cells was carried out with geneticin (G418, 800 mg ml
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, Life Technologies, Karlsruhe, Germany) for 3 weeks. Expression of hOCT1, hOCT2 and hOCT3 was veri®ed by RT ± PCR (data not shown) and functional characterization. ) Triton X-100, and 0.1 ml and 0.8 ml samples were assayed for protein content (by the method of Lowry et al., 1951) 
Transport assays
Results
Cloning of full-length hOCT2 and hOCT3
The full-length hOCT2 and hOCT3 cDNAs were cloned by RT ± PCR from SK-MG-1 cells and human kidney, respectively (Figure 1 ). Sequence analysis of the isolated cDNAs demonstrated that the deduced amino acid sequences were identical to the published hOCT2 and hOCT3 sequences (Gorboulev et al., 1997 , GruÈ ndemann et al., 1998 . Due to a very high GC content of the hOCT3 cDNA, GruÈ ndemann et al. (1998) failed to amplify the full-length cDNA; using the fail safe PCR system (see Methods) we were able to clone for the ®rst time the full-length hOCT3 cDNA. The cloning of the hOCT1 cDNA has been reported previously (Hayer et al., 1999) .
Expression of hOCT1, hOCT2 and hOCT3 in various human tumour cell lines RT ± PCR analysis of mRNA expression of hOCT1, hOCT2 and hOCT3 was performed with RNA from seven human cell lines which previously had been shown to express at least one human OCT (see Discussion). Figure 2 shows that the placenta cell line JAR expresses only the hOCT1 while all other examined cell lines express the hOCT1 and another hOCT. Thus, expression of hOCT1 and hOCT3 was observed in the glioma cell line Ski-1, the kidney carcinoma line Caki-1, the hepatoma line HepG-2 and the amnion line FL ( Figure  2) . Expression of all three hOCTs was shown for the intestinal cell line Caco-2 and the glioma line SK-MG-1 (Figure 2 (Figure 3a) . However, D22 was most potent at hOCT3 (IC 50 : 0.09 mM) and was about 10 fold less potent as inhibitor of hOCT1 and hOCT2 (IC 50 : about 1 mM).
O-methylisoprenaline (OMI) exhibited a selective hOCT3 inhibition (IC 50 : 4.4 mM), and it caused in concentrations up to 100 mM no signi®cant inhibition of hOCT1 or hOCT2 (Figure 3b) .
Corticosterone was found to be a potent, selective inhibitor of hOCT3 (IC 50 : 0.29 mM). With IC 50 values of 22 and 34 mM corticosterone was about 100 fold less potent as inhibitor of hOCT1 and hOCT2 (Table 1) .
As shown in Figure 3d and Table 1 , progesterone inhibited with about the same potency hOCT3 (IC 50 : 4.3 mM) and hOCT1 (IC 50 : 3.0 mM), and with an about 6 fold lower potency hOCT2. A similar preferential inhibition of hOCT3 and hOCT1 was also observed for b-oestradiol (IC 50 : 3 ± 6 mM; Figure 3e ; Table 1 ). However, in contrast to progesterone, b-oestradiol caused virtually no inhibition of hOCT2, at least not in concentrations up to 30 mM which almost completely inhibited hOCT3 and hOCT1 (Figure 3e) .
The a 1 -adrenoceptor antagonist prazosin most potently inhibited hOCT1 (IC 50 : 1.8 mM); it was 7 fold less potent at hOCT3, and concentrations up to 100 mM had no eect on hOCT2 (Figure 3f ; Table 1 ).
The irreversible a-adrenoceptor antagonist phenoxybenzamine (PbA) inhibited with about the same potency (IC 50 values between 2.7 and 6.1 mM) all three hOCTs, and the PbA analog SKF550 was highly potent at both, hOCT3 (IC 50 : 50 nM) and hOCT2 (IC 50 : 100 nM). However, SKF550 concentration up to 0.3 mM which almost completely Table 1 ).
Since there are con¯icting reports concerning the reversibility of PbA as inhibitor of`uptake 2 ' (see Discussion), we examined whether PbA (10 mM) and its analogue SKF550 (0.3 mM) are reversible or irreversible hOCT inhibitors. (Figure 4b) .
The reversibility of inhibition by PbA (100 mM) of the three hOCTs was dierent. At hOCT1, the PbA-eect was slowly reversed by washing of the cells, and after 60 min of washout no signi®cant inhibition was further detectable ( Figure  4a) . However, at hOCT2 and hOCT3 even wash-out for 60 min caused only a very small recovery of [ Since SKF550 (0.3 mM) had no eect at hOCT1, the reversibility of action of 0.3 mM SKF550 was examined only at cells expressing hOCT2 or hOCT3. At hOCT2 transport was re-established after 30 min of wash out (Figure 4d ), indicating reversible inhibition, whereas inhibition of hOCT3 by SKF550 was irreversible (Figure 4d ).
Discussion
We investigated the expression pattern of the three human organic cation transporters hOCT1, hOCT2 and hOCT3 in the human tumour cell lines Caki-1, SK-MG-1, Ski-1, HepG-2, FL, Caco-2 and the human choriocarcinoma line JAR. From these cells, expression of a functional`uptake 2 ' transporter and/or of OCT3 mRNA has been described for the kidney carcinoma cell line Caki-1 (SchoÈ mig & SchoÈ nfeld, 1990; GruÈ ndemann et al., 1998), the glioma cell lines SK-MG-1 (Streich et al., 1996) and Ski-1 (Chen et al., 1999) , the amnion epithelial cell line FL (Marino et al., 1993) , and the colon adenocarcinoma cell line Caco-2 (Martel et al., 2001) . The hepatocellular carcinoma line HepG-2 is known to express the hOCT1 (Sinclair et al., 2000) , and the human placenta (choriocarcinoma) line JAR has been shown to express the organic cation/carnitine transporter hOCTN2 (Wu et al., 1998b) . Only Caco-2 cells were known to express the mRNAs of all three hOCTs (Zhang et al., 1999; Bleasby et al., 2000; Martel et al., 2001) . Shown are arithmetic means+s.e.mean of n experiments carried out in triplicate.
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Functional discrimination of hOCT1, hOCT2 hOCT3 M. Hayer-Zillgen et al Using RT ± PCR we now demonstrate that all examined cell lines, except JAR, express at least two hOCTs, namely hOCT3 and hOCT1. OCT2 could only be detected in SK-MG-1 and Caco-2 cells, which expressed all three hOCTs. Although expression of hOCT2 had been described in placenta and kidney (Gorboulev et al., 1997), we could not amplify hOCT2 fragments from the placenta cell line JAR or the kidney cell line Caki-1.
Although SK-MG-1 cells express all three hOCT mRNAs, uptake of [ 3 H]-MPP + in these cells had previously been shown to be nearly completely sensitive to inhibition by OMI and thus almost exclusively mediated through`uptake 2 ', i.e., hOCT3 (Streich et al., 1996) . The small OMI-resistant component may represent uptake through hOCT1. Thus, whether cell lines which express two or three hOCT mRNAs also exhibit the corresponding transport activity remains to be shown. The here presented data on selective hOCT inhibitors should strongly facilitate such an eort.
In our search for selective inhibitors of hOCT1, hOCT2 or hOCT3 we examined eight compounds known from the literature to inhibit`uptake 2 '.
Decynium-22 (D22) has ®rst been described as a potent inhibitor of`uptake 2 ' (hOCT3) in the human cell line Caki-1 (K i : 16 nM; Russ et al., 1992) , and it was later shown to inhibit with about 20 ± 30 fold lower potency rat OCT1 (IC 50 of 0.36 mM; GruÈ ndemann et al., 1994) and rat OCT2 (IC 50 of 0.58 mM; Koepsell et al., 1999) . In the present study D22 exhibited highest potency (IC 50 : 90 nM) at hOCT3 and 10 fold lower potency at hOCT1 and hOCT2. The IC 50 value at hOCT1 (1 mM) agrees with literature values whereas the IC 50 value at hOCT2 is 10 fold lower . The reason for this discrepancy is unclear. At the porcine OCT2 D22 was a very potent inhibitor (IC 50 : 51 nM; GruÈ ndemann et al., 1997), indicating species dierences in the D22 sensitivity of OCT2.
O-Methylisoprenaline (OMI) is known as reversible and competitive`uptake 2 ' inhibitor which does not inhibit uptake 1 ' (Salt, 1972; BoÈ nisch & Trendelenburg, 1974) . In the present study OMI revealed to be the most selective hOCT3 inhibitor (IC 50 : 4.4 mM) with no eect at hOCT1 or hOCT2 at concentrations up to 100 mM. Inhibition by OMI of hOCT3 was rapidly washed-out and thus reversible. The IC 50 value at hOCT3 in HEK293 cells corresponds to that reported in SK-MG-1 cells which express`uptake 2 ' (Streich et al., 1996) , i.e., hOCT3. The low potency of OMI at hOCT2 agrees with previous reports at hOCT2 (IC 50 : 570 mM; Gorboulev et al., 1997), rat OCT2 (IC 50 : 2474 mM; Koepsell et al., 1999) and at porcine OCT2 (IC 50 : 880 mM; GruÈ ndemann et al., 1997). However, while 100 mM OMI caused no inhibition of the human OCT1, half maximal inhibition of the rat OCT1 by 43 mM OMI was reported by GruÈ ndemann et al. (1994) indicating species-speci®c dierences in the OMI sensitivity of the two species homologues of OCT1.
Sensitivity to corticosteroids has often been used to specify monoamine transport as transport by the extraneuronal uptake 2 ' transporter (Salt, 1972; BoÈ nisch, 1980) . Corticosteroids inhibit`uptake 2 ' through a non-genomic, competitive interaction (Bryan & O'Donnell, 1981) . Here we show that corticosterone is a potent (IC 50 : 0.29 mM) and selective inhibitor of hOCT3. Corticosterone was 100 fold less potent at hOCT1 (IC 50 : 22 mM) and hOCT2 (IC 50 : 34 mM). The high potency at hOCT3 corresponds to data obtained at Caki-1 and SK-MG-1 cells which express hOCT3 (SchoÈ mig & SchoÈ nfeld, 1990; Streich et al., 1996; GruÈ ndemann et al., 1998) . At the rat OCT3 corticosterone is by a factor of 10 less potent (IC 50 about 5 mM; Kekuda et al., 1998; Wu et al., 1998a) . At hOCT2 Koepsell et al. (1999) observed a similar potency of corticosterone (IC 50 : 29 mM) as we (see above). However, corticosterone exhibited higher potencies at OCT2 of the rat (IC 50 : 5.8 and 4.2 mM; Koepsell et al., 1999; Wu et al., 1998a) and the pig (IC 50 : 0.67 mM; GruÈ ndemann et al., 1997). The IC 50 value of 22 mM for corticosterone at hOCT1 obtained in the present study is in the same order of magnitude as that reported at hOCT1 by Koepsell et al. (1999) . However, at the rat OCT1 corticosterone exhibits a more than 20 fold lower potency (IC 50 : 160 mM; GruÈ ndemann et al., 1994) than at the hOCT1 (see above). Thus, OCTs show also pronounced species dierences in their sensitivity to corticosterone.
The sex steroids progesterone and b-oestradiol are known to inhibit competitively at micromolar concentrations thè uptake 2 ' transport system (Salt, 1972; BoÈ nisch, 1980; Grohmann & Trendelenburg, 1984) . In the present study progesterone inhibited with the same potency (IC 50 : 3 ± 4 mM) hOCT3 and hOCT1 and with an about 7 fold lower potency (IC 50 : 26 mM) hOCT2. However, progesterone was shown to be about 7 fold more potent at rOCT2 than at rOCT3 (Wu et al., 1998a) . At the human OCTs b-oestradiol was a preferential inhibitor of hOCT3 and hOCT1 (IC 50 : 3 ± 6 mM) and concentrations up to 30 mM caused no inhibition of hOCT2. The inhibition data of b-oestradiol at hOCT3 and hOCT2 agree with those reported by Wu et al. (1998a) at the corresponding rat OCTs.
The a 1 -adrenoceptor antagonist prazosin had previously been shown to competitively inhibit rat`uptake 2 ' with a potency similar to that of OMI (Grohmann & Trendelenburg, 1984; Akimoto et al., 1989) . We now demonstrate that prazosin is not only an inhibitor of hOCT3 (IC 50 : 12.5 mM) but an even more selective and more potent inhibitor of hOCT1 (IC 50 : 1.8 mM) which in concentrations up to 100 mM causes no inhibition of hOCT2. Lightman & Iversen (1969) showed that the irreversible aadrenoceptor antagonist phenoxybenzamine (PbA) is a potent and competitive inhibitor of`uptake 2 ' in the isolated perfused rat heart (IC 50 : 2.5 mM). However, according to Bryan & O'Donnell (1981) PbA is a non-competitive and irreversible`uptake 2 ' inhibitor. Since nothing was known about PbA eects at human OCTs we studied the potency and reversibility of its interaction at the three hOCTs. We could show that PbA inhibits with about the same apparent potency (IC 50 : 3 ± 6 mM) all three human OCTs. The inhibition by PbA of hOCT2 and hOCT3 was found to be irreversible (see Figure 4 ). According to Iversen et al. (1972) the PbA derivative SKF550 is in the rat heart the most potent`uptake 2 ' inhibitor (IC 50 : 0.08 mM). In the present study SKF550 revealed to be the most potent inhibitor of both, hOCT3 (IC 50 : 50 nM) and hOCT2 (IC 50 : 100 nM); however, SKF550 had no eect on hOCT1 in concentrations up to 0.3 mM. Haloalkylamines such as PbA and SKF550 form an unstable aziridinium ion which via the highly reactive intermediate ethyleneiminium ion forms covalent bonds with sulfhydryl, hydroxy, amino and carboxy groups of amino acids of target proteins (Jenkinson, 1996) . Cysteines are known to be the most reactive among the amino acid residues (Shulman-Roskes et al., 1998) and a cysteine residue in transmembrane domain 3 of the a 2 -adrenoceptor has recently been identi®ed as a possible site for the irreversible PbA interaction at this receptor (Frang et al., 2001) . However, amino acid sequence alignment of the three hOCTs (data not shown) did not give a hint for a cysteine (or serine or threonine or tyrosine) as possible site of interaction of PbA and SKF550 at the hOCT3.
In summary, this is the ®rst pharmacological comparison of the three OCTs of one species (human) performed under identical conditions in human cells stably expressing hOCT1, hOCT2, or hOCT3. Using various substances known to inhibit at least the`uptake 2 ' transporter OCT3, we identi®ed inhibitors that allow functional discrimination of the three human OCTs. Thus, hOCT1 is characterized by the potency order D224prazosin4PbA4progesterone5b-oestradiol4 corticosterone44OMI, hOCT2 by the order SKF5504 D224PbA4progesterone5corticosterone4b-oestradiol4O-MI=prazosin, and hOCT3 by the order SKF5504D224cor-ticosterone4b-oestradiol4progesterone=OMI5PbA4pra-zosin. The availability of some relatively selective OCT inhibitors should facilitate the investigation of the physiological functions of these transport systems in kidney, liver, intestine and brain.
